The Risks of Venous Thromboembolic Disease Among German Women Using Oral Contraceptives: A Database Study
- 1 February 1998
- journal article
- Published by Elsevier in Contraception
- Vol. 57 (2) , 67-70
- https://doi.org/10.1016/s0010-7824(98)00002-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Population-based study of risk of venous thromboembolism associated with various oral contraceptivesThe Lancet, 1997
- The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational researchContraception, 1996
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Third generation oral contraceptive pillsBMJ, 1995
- The risk of venous thromboembolism associated with low oestrogen oral contraceptivesJournal of Obstetrics and Gynaecology, 1995
- Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic DiseaseAmerican Journal of Epidemiology, 1991
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986